We defined a confirmed case as the occurrence of clinical symptoms consistent with respiratory diphtheria (sore throat; low-grade fever; and an adherent membrane on the pharynx, tonsils, larynx, or nose) in a person who was positive for toxin-producing C.
Use of these tools will minimize the risk of importation of C.
During the study period (1998-2004) the rate of detection of C.
Antibiotics are administered to patients suspected with diphtheria to eradicate carriage of C.
The 5 recent cases of functional toxin gene bearing cutaneous C.
In response to isolation of this organism, the South Dakota Department of Health (SDDOH), the Aberdeen Area Office of the IHS, and CDC initiated enhanced surveillance to evaluate the possibility of C.
After years of stagnation, the number of complete C.
ulcerans in the United States and the continued risk for importation of toxigenic C.
This phenomenon has not been documented in any countries reporting nontoxigenic C.
Clinical manifestations and immunization status for case-patients with toxigenic C.
ulcerans have outnumbered those caused by toxigenic C.
Culture of an otic swab collected from the cat in May 2007 yielded 4 organisms: C.